JPWO2020014143A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020014143A5 JPWO2020014143A5 JP2021523556A JP2021523556A JPWO2020014143A5 JP WO2020014143 A5 JPWO2020014143 A5 JP WO2020014143A5 JP 2021523556 A JP2021523556 A JP 2021523556A JP 2021523556 A JP2021523556 A JP 2021523556A JP WO2020014143 A5 JPWO2020014143 A5 JP WO2020014143A5
- Authority
- JP
- Japan
- Prior art keywords
- population
- heavy chain
- light chain
- antibody
- nucleic acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023129892A JP2023145778A (ja) | 2018-07-08 | 2023-08-09 | 抗体の開発可能性が最大化された抗体ライブラリー |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862695065P | 2018-07-08 | 2018-07-08 | |
US62/695,065 | 2018-07-08 | ||
US201962822671P | 2019-03-22 | 2019-03-22 | |
US62/822,671 | 2019-03-22 | ||
PCT/US2019/040843 WO2020014143A1 (fr) | 2018-07-08 | 2019-07-08 | Banques d'anticorps ayant des caractéristiques maximisées d'aptitude au développement d'anticorps |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023129892A Division JP2023145778A (ja) | 2018-07-08 | 2023-08-09 | 抗体の開発可能性が最大化された抗体ライブラリー |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2021531822A JP2021531822A (ja) | 2021-11-25 |
JPWO2020014143A5 true JPWO2020014143A5 (fr) | 2022-11-04 |
JP7332691B2 JP7332691B2 (ja) | 2023-08-23 |
Family
ID=69102540
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021523556A Active JP7332691B2 (ja) | 2018-07-08 | 2019-07-08 | 抗体の開発可能性が最大化された抗体ライブラリー |
JP2023129892A Pending JP2023145778A (ja) | 2018-07-08 | 2023-08-09 | 抗体の開発可能性が最大化された抗体ライブラリー |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023129892A Pending JP2023145778A (ja) | 2018-07-08 | 2023-08-09 | 抗体の開発可能性が最大化された抗体ライブラリー |
Country Status (5)
Country | Link |
---|---|
US (5) | US10954508B2 (fr) |
EP (1) | EP3833685A4 (fr) |
JP (2) | JP7332691B2 (fr) |
CA (1) | CA3106115A1 (fr) |
WO (1) | WO2020014143A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3169710A1 (fr) * | 2014-07-14 | 2017-05-24 | Amgen Inc. | Formulations d'anticorps cristallins |
CN118103065A (zh) * | 2021-07-07 | 2024-05-28 | 儒勒斯贝斯特医药有限公司 | 使用天然无不利因素cdr的抗体亲和力成熟 |
US20240093179A1 (en) * | 2022-02-17 | 2024-03-21 | Specifica, Inc. | Single domain antibody libraries with maximized antibody developability characteristics |
WO2023232857A1 (fr) * | 2022-06-03 | 2023-12-07 | Ichnos Sciences SA | Bibliothèques d'anticorps à chaîne légère commune |
WO2024083925A2 (fr) * | 2022-10-18 | 2024-04-25 | Tubulis Gmbh | Nouveaux anticorps anti-napi2b et conjugués anticorps-médicament basés sur ceux-ci, procédés thérapeutiques et utilisations de ceux-ci |
CN118496354A (zh) * | 2023-02-15 | 2024-08-16 | 三优生物医药(上海)有限公司 | 包含共同轻链的抗体库、其制备方法及其用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ312332A (en) | 1995-06-07 | 2000-01-28 | Life Technologies Inc | Recombinational cloning using engineered recombination sites |
EP1054018B1 (fr) | 1999-05-18 | 2009-01-28 | Dyax Corp. | Banques de fragments Fab et leurs procédes d'utilisation |
GB0008419D0 (en) | 2000-04-05 | 2000-05-24 | Bioinvent Int Ab | A method for invitro molecular evolution of antibody function |
US8288322B2 (en) | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
US20060160178A1 (en) | 2003-11-17 | 2006-07-20 | Jonathan Rothberg | Methods of generating antibody diversity in vitro |
CA2964398C (fr) | 2007-09-14 | 2023-03-07 | Adimab, Llc | Bibliotheques d'anticorps synthetiques rationnelles et leurs utilisations |
EP2356270B1 (fr) | 2008-11-07 | 2016-08-24 | Fabrus Llc | Bibliothèques combinatoires d'anticorps et leurs utilisations |
WO2016114567A1 (fr) * | 2015-01-13 | 2016-07-21 | 이화여자대학교 산학협력단 | Procédé de préparation d'une nouvelle bibliothèque d'anticorps et bibliothèque ainsi préparée |
WO2019126227A1 (fr) * | 2017-12-18 | 2019-06-27 | Distributed Bio, Inc. | Banque d'anticorps humains radicalement divers |
-
2019
- 2019-07-08 CA CA3106115A patent/CA3106115A1/fr active Pending
- 2019-07-08 EP EP19834483.0A patent/EP3833685A4/fr active Pending
- 2019-07-08 WO PCT/US2019/040843 patent/WO2020014143A1/fr unknown
- 2019-07-08 JP JP2021523556A patent/JP7332691B2/ja active Active
- 2019-07-08 US US16/505,358 patent/US10954508B2/en active Active
-
2021
- 2021-01-29 US US17/163,170 patent/US11920258B2/en active Active
- 2021-03-22 US US17/208,877 patent/US11254931B2/en active Active
-
2023
- 2023-08-09 JP JP2023129892A patent/JP2023145778A/ja active Pending
-
2024
- 2024-02-29 US US18/592,473 patent/US20240229297A1/en active Pending
- 2024-02-29 US US18/592,456 patent/US20240240360A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2023145778A5 (fr) | ||
Carmena et al. | Transposable elements map in a conserved pattern of distribution extending from beta-heterochromatin to centromeres in Drosophila melanogaster | |
EP1032660B1 (fr) | Procede pour identifier des domaines de sites de fixation qui preservent leur capacite de fixation sur un epitope | |
McConnell et al. | Tendamistat as a scaffold for conformationally constrained phage peptide libraries | |
DE69621940T2 (de) | Protein-/(poly)peptidbibliotheken | |
ES2609102T3 (es) | Mutagénesis por revisión | |
CN103282560B (zh) | 抗体文库 | |
JP7332691B2 (ja) | 抗体の開発可能性が最大化された抗体ライブラリー | |
Liu et al. | Fine mapping of the antigen–antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster | |
JP2018520639A5 (fr) | ||
JPH08294393A (ja) | オリゴヌクレオチド組成物 | |
Morino et al. | Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression | |
RU2014133653A (ru) | Гуманизированные грызуны, которые экспрессируют тяжелые цепи, содержащие домены vl | |
IE910336A1 (en) | Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries") | |
JP2012504401A5 (fr) | ||
JPWO2020014143A5 (fr) | ||
CN113603775B (zh) | 抗人白介素-33单克隆抗体及其应用 | |
Ota et al. | Evolution of immunoglobulin VH pseudogenes in chickens. | |
RU99101121A (ru) | Полипептиды, способные к образованию антигенсвязывающих структур со специфичностью к резус-d-антигенам, днк, кодирующая их, способы их получения и применение | |
US20230071129A1 (en) | Polyclonal mixtures of antibodies, and methods of making and using them | |
Akashi et al. | Antigenic diversity of Akabane virus detected by monoclonal antibodies | |
Lieberman et al. | Close linkage in genes controlling γA and γG heavy chain structure in BALB/c mice | |
Esteban et al. | Generation and characterisation of functional recombinant antibody fragments against RNA replicase NIb from plum pox virus | |
Early et al. | Immunoglobulin gene rearrangements in normal mouse B cells | |
AU2016202118B2 (en) | Carrier immunoglobulins and uses thereof |